# OnCo record nct07424287 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07424287/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07424287", "NCT07424287" ;
  schema:name "A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC"@en ;
  schema:alternateName "NiBladder 1"@en ;
  schema:description "A phase 3 trial testing SHR-1501 in bladder & urothelial cancer, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07424287/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07424287> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2026-07-13" ;
  onco:cancers <https://onco.cc/cancers/urothelial/>, <https://onco.cc/cancers/non-muscle-invasive-bladder-cancer/> ;
  onco:drugs <https://onco.cc/drugs/shr-1501/>, <https://onco.cc/drugs/pirarubicin/> ;
  onco:companies <https://onco.cc/companies/hengrui/> .